134 related articles for article (PubMed ID: 11961156)
1. Macrolide-resistant group a streptococcus--now in the United States.
Huovinen P
N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
[No Abstract] [Full Text] [Related]
2. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
4. Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy.
D'Ercole S; Petrelli D; Prenna M; Zampaloni C; Catania MR; Ripa S; Vitali LA
Clin Microbiol Infect; 2005 Nov; 11(11):927-30. PubMed ID: 16216111
[TBL] [Abstract][Full Text] [Related]
5. [Resistance to macrolides in Streptococcus pyogenes].
Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
[No Abstract] [Full Text] [Related]
6. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
[No Abstract] [Full Text] [Related]
7. Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.
Haller M; Fluegge K; Arri SJ; Adams B; Berner R
Antimicrob Agents Chemother; 2005 Jul; 49(7):2990-3. PubMed ID: 15980381
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin-resistant group A streptococci.
Linder JA; Stafford RS
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
[No Abstract] [Full Text] [Related]
9. Erythromycin-resistant group A streptococci.
Shulman ST; Tanz R; Kabat W
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12195586
[No Abstract] [Full Text] [Related]
10. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
Yazgi H; Ertek M; Aktaş AE
Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
[TBL] [Abstract][Full Text] [Related]
11. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
14. Low macrolide resistance in Streptococcus pyogenes in Southern Argentina.
Rubinstein G; Amoroso AM; Bavdaz B; De Bunder S; Blazquez N; Gutkind GO
Int J Antimicrob Agents; 2005 May; 25(5):450-2. PubMed ID: 15848305
[No Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
[TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
[No Abstract] [Full Text] [Related]
17. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
[No Abstract] [Full Text] [Related]
18. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.
Martin JM; Green M; Barbadora KA; Wald ER
N Engl J Med; 2002 Apr; 346(16):1200-6. PubMed ID: 11961148
[TBL] [Abstract][Full Text] [Related]
19. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
[No Abstract] [Full Text] [Related]
20. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin.
Kataja J; Huovinen P; Efstratiou A; Pérez-Trallero E; Seppälä H;
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):589-95. PubMed ID: 12226689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]